Bioalpha Holdings Bhd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioalpha Holdings Bhd with three other
pharmaceutical manufacturers in Asia:
Nutraplus India Ltd
sales of 1.09 billion Indian Rupees [US$15.35 million]
Mezzion Pharma Co Ltd
of South Korea
(19.09 billion Korean Won [US$15.92 million]
of which 88%
was Feed Segment), and
Ngl Fine Chem Ltd
based in India
(1.14 billion Indian Rupees [US$15.98 million]
Bioalpha Holdings Bhd reported sales of 70.09 million Malaysian Ringgits (US$16.70 million)
December of 2018.
increase of 25.3%
versus 2017, when the company's sales were 55.92 million Malaysian Ringgits.
Sales at Bioalpha Holdings Bhd have increased during each of the previous five years
(and since 2013, sales have increased a total of 185%).